Depo-medrol and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Depo-medrol (methylprednisolone acetate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Osteoporosis.

The phase IV clinical study analyzes which people have Cellulitis when taking Depo-medrol. It is created by eHealthMe based on reports of 5,847 people who have side effects when taking Depo-medrol from the FDA, and is updated regularly.

What is Depo-medrol?

Depo-medrol has active ingredients of methylprednisolone acetate. It is often used in birth control. eHealthMe is studying from 5,933 Depo-medrol users. Check the latest studies of Depo-medrol.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,105 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jul, 14, 2026

5,847 people reported to have side effects when taking Depo-medrol.
Among them, 100 people (1.71%) have Cellulitis.

Among these 100 people:

How long have people been on Depo-medrol when they have Cellulitis? *

What is the gender of people who have Cellulitis when taking Depo-medrol? *

female: 77.42 %
male: 22.58 %

What is the age of people who have Cellulitis when taking Depo-medrol? *

What are other drugs people take besides Depo-medrol? *

What are other side effects people have besides Cellulitis? *

Stress And Anxiety: 44 people, 44.00%
Back Pain: 43 people, 43.00%
Pain: 39 people, 39.00%
Pain In Extremity: 36 people, 36.00%
Osteonecrosis Of Jaw (death of bone of jaw): 32 people, 32.00%
Fatigue (feeling of tiredness): 32 people, 32.00%
Oedema Peripheral (superficial swelling): 32 people, 32.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 32 people, 32.00%
Weakness: 32 people, 32.00%
Depression: 28 people, 28.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 16 people, 16.00%
Metastases To Bone (cancer spreads to bone): 11 people, 11.00%
Pain: 10 people, 10.00%
Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 10 people, 10.00%
Breast Cancer: 10 people, 10.00%
Multiple Myeloma (cancer of the plasma cells): 8 people, 8.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 7 people, 7.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 7.00%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 5 people, 5.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Depo-medrol and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Depo-medrol:

Depo-medrol (5,933 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Depo-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,105 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,338 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone acetate (the active ingredients of Depo-medrol) and Depo-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.